Lab-Grown vaginas: first human trial launches
NCT ID NCT05675722
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 1 trial tests a lab-grown vaginal implant made from a patient's own cells for women with vaginal aplasia (born without a vagina). Ten participants will receive the implant to see if it is safe and can improve quality of life. The implant is designed to mimic natural vaginal tissue and avoid rejection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lab-grown vaginal tissue made from the patient's own cells
- What this could lead to
- If successful, this could offer a new treatment option for women born without a vagina, potentially avoiding the need for repeated surgeries.
- What could go wrong
- This is a very early Phase 1 trial with only 10 people. It is designed mainly to check safety, not effectiveness. Risks include bleeding, pain, infection, or scarring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL MULLERIAN DUCT ANOMALY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest University Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States